Reviewers question CV risks/clinical benefit of testosterone therapies

In Clarus Therapeutics Inc. (Northbrook, Ill.) for Rextoro, an oral testosterone under review as testosterone replacement therapy in males with primary or hypogonadotropic hypogonadism. FDA has not ye...